Clinical Trials in India and China

India and China, two of the worlds most populous countries and once considered difficult markets to enter, have taken significant strides as emerging markets in drug development. It is no coincidence over the last decade or more of economic liberalization, and years of unprecedented growth, that India and China are becoming a preferred clinical research destination for multinational pharmaceutical and biotechnology corporations. Cost-savings are a significant draw card for many pharmaceutical companies when deciding to outsource clinical research to countries in emerging markets such as India and China.

This event focuses on the real issues that matter when setting up trials in nontraditional countries. In todays ultra-competitive marketplace, companies are pushing the limits for running trials in traditional countries. Learn from successful company stories that have relocated their operations to emerging companies and explore the challenges that are involved.

The conference aims to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and China, and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and China, selection and role of CROs, logistics of operations, clinical trials management, government policies (including IPR issues) and pharmacovigilance.

Reasons to register today:

Summarise methods to make informed decisions about conducting clinical studies from a biopharmaceutical perspective
Identify the data management, CMC supply chain, operational requirements and CRO infrastructure in India and China
Discuss the regulatory requirements and implication of conducting these studies in India and China
Explain government regulation and legal infrastructure in India and China
Discover how to improve your supplier-client relationships
Complete trials on schedule and budget by learning to overcome hurdles in investigator/patient recruitment
What are the issues with off-shoring trials to countries such as China, India and Latin America, and ways to overcome them?
Explore innovative strategies for outsourcing, what you should be looking for in a CRO?
What considerations are involved in writing and managing a sensible contract?
How can you take advantage of the global market for clinical trials?

Key speakers:
AstraZeneca
Pfizer
Lundbeck
Excel-China
Draco Healthcare
TTC-LLC
Good Clinical Practice Alliance
Davies Arnold Cooper
Excel PharmaStudies
Fisher Clinical Services
Lambda Therapeutics Research
Institute of Clinical Research India

Who Should Attend?
Pharmaceutical, biotech and CROs, Directors and Heads of:
Clinical Research and Development
Clinical Research Services
Clinical Operations
Clinical Data Management
Clinical IT
Clinical Trials
Medical Affairs
Regulatory Affairs
Compliance
Quality Control/Assurance/GCP
Clinical Study Design
Safety Surveillance
Subject Recruitment
E-Clinical Systems

Weblink: www.visiongain.com